Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT. This is an
overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote on these important matters. The proxy materials are available to you on the Internet. You may view
these materials online at www.proxyvote.com or request a paper or an email copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting. Prefer to
receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. 1. Election of Directors: 1a. David M. Cordani For 1b. Brian C. Evanko For 1c. Eric J. Foss For 1d. Neesha
Hathi For 1e. Michael J. Hennigan For 1f. George Kurian For 1g. Kathleen M. Mazzarella For 1h. Mark B. McClellan, M.D., Ph.D. For 1i. Philip O. Ozuah, M.D., Ph.D. For 1j. Kimberly A. Ross For 1k. Eric C.
Wiseman For 1l. Donna F. Zarcone For 2. Advisory approval of executive compensation For 3. Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for
2026 For 4. Shareholder Proposal — Shareholder Right to Act by Written Consent Against Note: Such other business as may properly come before the meeting or any postponements or adjournments thereof Our board has fixed the close of
business on February 23, 2026 as the record date for the determination of shareholders entitled to notice of, and to vote at, the meeting and any adjournments thereof. A list of shareholders will be made available to shareholders during
ordinary business hours for a period of at least ten days ending on the day before the meeting date at www.virtualshareholdermeeting.com/CI2026. Voting Items Board Recommends V83627-P42812-Z91840